Muscarinic receptors and their antagonists in COPD: Anti-inflammatory and antiremodeling effects

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Karakiulakis, George ^a   Roth, Michael ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; GLYCOSAMINOGLYCAN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYALURONIC ACID; MATRIX METALLOPROTEINASE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; ANTIINFLAMMATORY AGENT; COLLAGEN;

ACETYLCHOLINE RELEASE; AIRWAY REMODELING; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; BRONCHUS MUCOSA; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENZYME DEGRADATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; INTRACELLULAR SIGNALING; LUNG PARENCHYMA; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; VASODILATATION; ANIMAL; CLASSIFICATION; DRUG EFFECT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AIRWAY REMODELING; ANIMALS; ANTI-INFLAMMATORY AGENTS; COLLAGEN; GLYCOSAMINOGLYCANS; HUMANS; MATRIX METALLOPROTEINASES; MUSCARINIC ANTAGONISTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION;

EID: 84871398341     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/409580     Document Type: Review

References (87)

1. + channel, I(KACh). Annals of the New York Academy of Sciences 1999 868 386 398 2-s2.0-0032968704 10.1111/j.1749-6632.1999. tb11300.x (Pubitemid 29281139)
2. Eglen R. M., Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Autonomic and Autacoid Pharmacology 2006 26 3 219 233 2-s2.0-33745168973 10.1111/j.1474-8673.2006.00368.x (Pubitemid 43898622)
3. Felder C. C., Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB Journal 1995 9 8 619 625 2-s2.0-0029013930
4. Hall R. A., Premont R. T., Lefkowitz R. J., Hetahelical receptor signaling: beyond the G protein paradigm. Journal of Cell Biology 1999 145 5 927 932 2-s2.0-0033620487 10.1083/jcb.145.5.927 (Pubitemid 29270052)
5. Caulfield M. P., Birdsall N. J. M., International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacological Reviews 1998 50 2 279 290 2-s2.0-0031774720 (Pubitemid 28304029)
6. Acetylcholine Receptors (Muscarinic), IUPHAR Database of Receptors and Ion Channels, International Union of Basic and Clinical Pharmacology, http://www.iuphar-db.org/GPCR/ChapterMenuForward?chapterID=1271
7. MeSH Browser, 2012, http://www.nlm.nih.gov/mesh/2012/mesh-browser/ MBrowser.html
8. Peralta E. G., Ashkenazi A., Winslow J. W., Smith D. H., Ramachandran J., Capon D. J., Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. The EMBO Journal 1987 6 13 3923 3929 2-s2.0-0023661365
9. Bonner T. I., Young A. C., Bran M. R., Buckley N. J., Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1988 1 5 403 410 2-s2.0-0024039146
10. Hosey M. M., Diversity of structure, signaling and regulation within the family of muscarinic cholinergic receptors. FASEB Journal 1992 6 3 845 852 2-s2.0-0026813907
11. Forsythe S. M., Kogut P. C., McConville J. F., Fu Y., McCauley J. A., Halayko A. J., Wei Liu H., Kao A., Fernandes D. J., Bellam S., Fuchs E., Sinha S., Bell G. I., Camoretti-Mercado B., Solway J., Structure and transcription of the human m3 muscarinic receptor gene. American Journal of Respiratory Cell and Molecular Biology 2002 26 3 298 305 2-s2.0-0036008398 (Pubitemid 34170056)
12. Eglen R. M., Nahorski S. R., The muscarinic M5 receptor: a silent or emerging subtype? British Journal of Pharmacology 2000 130 1 13 21 2-s2.0-0034017317 (Pubitemid 30248420)
13. Nathanson N. M., A multiplicity of muscarinic mechanisms: enough signaling pathways to take your breath away. Proceedings of the National Academy of Sciences of the United States of America 2000 97 12 6245 6247 2-s2.0-0034612293 10.1073/pnas.97.12.6245 (Pubitemid 30412696)
14. van Koppen C. J., Kaiser B., Regulation of muscarinic acetylcholine receptor signaling. Pharmacology and Therapeutics 2003 98 2 197 220 2-s2.0-0037406701 10.1016/S0163-7258(03)00032-9 (Pubitemid 36513775)
15. Rosenblum K., Futter M., Jones M., Hulme E. C., Bliss T. V. P., ERKI/II regulation by the muscarinic acetylcholine receptors in neurons. Journal of Neuroscience 2000 20 3 977 985 2-s2.0-0034143365 (Pubitemid 30220454)
16. Profita M., Bonanno A., Montalbano A. M., Ferraro M., Siena L., Bruno A., Girbino S., Albano G. D., Casarosa P., Pieper M. P., Gjomarkaj M., Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro. Life Sciences 2011 89 1-2 36 43 2-s2.0-79959346315 10.1016/j.lfs.2011.04.025
17. Oenema T. A., Kolahian S., Nanninga J. E., Rieks D., Hiemstra P. S., Zuyderduyn S., Halayko A. J., Meurs H., Gosens R., Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle. Respiratory Research 2010 11, article 130 2-s2.0-79551608638 10.1186/1465-9921-11-130
18. Gosens R., Zaagsma J., Meurs H., Halayko A. J., Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respiratory Research 2006 7, article 73 2-s2.0-33745218112 10.1186/1465-9921-7-73 (Pubitemid 43905817)
19. Mak J. C., Baraniuk J. N., Barnes P. J., Localization of muscarinic receptor subtype mRNAs in human lung. American Journal of Respiratory Cell and Molecular Biology 1992 7 3 344 348 2-s2.0-0026917239
20. Ikeda T., Anisuzzaman A. S., Yoshiki H., Sasaki M., Koshiji T., Uwada J., Nishimune A., Itoh H., Muramatsu I., Regional quantification of muscarinic acetylcholine receptors and β -adrenoceptors in human airways. British Journal of Pharmacology 2012 166 1804 1814
21. Kistemaker L. E., Oenema T. A., Meurs H., Gosens R., Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. Life Sciences 2012 91 21-22 1126 1133
22. Milara J., Serrano A., Peiró T., Aclidinium inhibits human lung fibroblast to myofibroblast transition. Thorax 2012 67 3 229 237
23. Lammers J. W. J., Minette P., McCusker M., Barnes P. J., The role of prinzepine-sensitive (M1) muscarinic receptors in vagally mediated bronchoconstriction in humans. American Review of Respiratory Disease 1989 139 2 446 449 2-s2.0-0024476743 (Pubitemid 19057423)
24. Gies J. P., Bertrand C., Vanderheyden P., Waeldele F., Dumont P., Pauli G., Landry Y., Characterization of muscarinic receptors in human, guinea pig and rat lung. Journal of Pharmacology and Experimental Therapeutics 1989 250 1 309 315 2-s2.0-0024335443 (Pubitemid 19195006)
25. Patel H. J., Barnes P. J., Takahashi T., Tadjkarimi S., Yacoub M. H., Belvisi M. G., Evidence for prejunctional muscarinic autoreceptors in human and guinea pig trachea. American Journal of Respiratory and Critical Care Medicine 1995 152 3 872 878 2-s2.0-0029091990
26. Ten Berge R. E. J., Zaagsma J., Roffel A. F., Muscarinic inhibitory autoreceptors in different generations of human airways. American Journal of Respiratory and Critical Care Medicine 1996 154 1 43 49 2-s2.0-0030017258 (Pubitemid 26255765)
27. Roux E., Molimard M., Savineau J. P., Marthan R., Muscarinic stimulation of airway smooth muscle cells. General Pharmacology 1998 31 3 349 356 2-s2.0-0032168819 10.1016/S0306-3623(98)00007-X (Pubitemid 28398857)
28. Roffel A. F., Elzinga C. R. S., Van Amsterdam R. G. M., De Zeeuw R. A., Zaagsma J., Muscarinic M2 receptor in bovine tracheal smooth muscle: discrepancies between binding and function. European Journal of Pharmacology 1988 153 1 73 82 2-s2.0-0023822129
29. Eglen R. M., Hegde S. S., Watson N., Muscarinic receptor subtypes and smooth muscle function. Pharmacological Reviews 1996 48 4 531 565 2-s2.0-0030442725 (Pubitemid 27023820)
30. Roffel A. F., Elzinga C. R., Zaagsma J., Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulmonary Pharmacology 1990 3 1 47 51 2-s2.0-0025191514 10.1016/0952-0600(90)90009-8 (Pubitemid 20187064)
31. Villetti G., Pastore F., Bergamaschi M., Bassani F., Bolzoni P. T., Battipaglia L., Amari G., Rizzi A., Delcanale M., Volta R., Cenacchi V., Cacciani F., Zaniboni M., Berti F., Rossoni G., Harrison S., Petrillo P., Santoro E., Scudellaro R., Mannini F., Geppetti P. A., Razzetti R., Patacchini R., Civelli M., Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl) [(3,4,5-trifluorophenyl)methyl]amino]carbonyl] oxy]-1-[2-oxo-2-(2-thienyl)ethyl] -1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 2010 335 3 622 635 2-s2.0-78649547027 10.1124/jpet.110.170035
32. Paredes-Gamero E. J., Medeiros V. P., Farias E. H. C., Justo G. Z., Trindade E. S., Andrade-Lopes A. L., Godinho R. O., De Miranda A., Ferreira A. T., Tersariol I. L. S., Nader H. B., Heparin induces rat aorta relaxation via integrin-dependent activation of muscarinic M3 receptors. Hypertension 2010 56 4 713 721 2-s2.0-77957224404 10.1161/HYPERTENSIONAHA.110.156877
33. Wessler I., Kirkpatrick C. J., Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. British Journal of Pharmacology 2008 154 8 1558 1571 2-s2.0-49449094458 10.1038/bjp.2008.185
34. Koarai A., Traves S. L., Fenwick P. S., Expression of muscarinic receptors by human macrophages. European Respiratory Journal 2012 39 3 698 704
35. Moffatt J. D., Cocks T. M., Page C. P., Role of the epithelium and acetylcholine in mediating the contraction to 5-hydroxytryptamine in the mouse isolated trachea. British Journal of Pharmacology 2004 141 7 1159 1166 2-s2.0-2342622638 10.1038/sj.bjp.0705720 (Pubitemid 38582253)
36. Kummer W., Wiegand S., Akinci S., Schinkel A. H., Wess J., Koepsell H., Haberberger R. V., Lips K. S., Role of acetylcholine and muscarinic receptors in serotonin-induced bronchoconstriction in the mouse. Journal of Molecular Neuroscience 2006 30 1-2 67 68 2-s2.0-33845920612 10.1385/JMN:30:1:67 (Pubitemid 46035323)
37. Petrie G. R., Palmer K. N. V., Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma. British Medical Journal 1975 1 5955 430 432 2-s2.0-0016438267
38. Barnes P. J., Tiotropium bromide. Expert Opinion on Investigational Drugs 2001 10 4 733 740 2-s2.0-0035066874 10.1517/13543784.10.4.733 (Pubitemid 32288190)
39. Disse B., Speck G. A., Rominger K. L., Witek T. J., Hammer R., Tiotropium (spiriva(TM)): mechanistical considerations and clinical profile in obstructive lung disease. Life Sciences 1999 64 6-7 457 464 2-s2.0-0033534194 10.1016/S0024-3205(98)00588-8 (Pubitemid 29066693)
40. Ohar J. A., Donohue J. F., Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD. Seminars in Respiratory and Critical Care Medicine 2010 31 3 321 333 2-s2.0-77953314140 10.1055/s-0030-1254072
41. Minette P. A. H., Lammers J. W. J., Dixon C. M. S., McCusker M. T., Barnes P. J., A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. Journal of Applied Physiology 1989 67 6 2461 2465 2-s2.0-0024850599 (Pubitemid 20032248)
42. Nie Z., Jacoby D. B., Fryer A. D., Etanercept prevents airway hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. British Journal of Pharmacology 2009 156 1 201 210 2-s2.0-65549128183 10.1111/j.1476-5381.2008.00045.x
43. Jacoby D. B., Gleich G. J., Fryer A. D., Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. Journal of Clinical Investigation 1993 91 4 1314 1318 2-s2.0-0027232088 (Pubitemid 23127327)
44. Matthiesen S., Bahulayan A., Kempkens S., Haag S., Fuhrmann M., Stichnote C., Juergens U. R., Racké K., Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. American Journal of Respiratory Cell and Molecular Biology 2006 35 6 621 627 2-s2.0-33845397124 10.1165/rcmb.2005-0343RC (Pubitemid 44901851)
45. Selivanova P. A., Kulikov E. S., Kozina O. V., Gereng E. A., Freidin M. B., Ogorodova L. M., Morphological and molecular characteristics of "difficult" asthma. Journal of Asthma 2010 47 3 269 275 2-s2.0-77951142669 10.3109/02770900903584001
46. Selivanova P. A., Kulikov E. S., Kozina O. V., Trofimenko I. N., Freidin M. B., Chernyak B. A., Ogorodova L. M., Differential expression of the β2-adrenoreceptor and M3-cholinoreceptor genes in bronchial mucosa of patients with asthma and chronic obstructive pulmonary disease. Annals of Allergy, Asthma & Immunology 2012 108 1 39 43
47. Barnes P. J., Immunology of asthma and chronic obstructive pulmonary disease. Nature Reviews Immunology 2008 8 3 183 192 2-s2.0-40049104892 10.1038/nri2254 (Pubitemid 351323287)
48. Hogg J. C., Chu F., Utokaparch S., Woods R., Elliott W. M., Buzatu L., Cherniack R. M., Rogers R. M., Sciurba F. C., Coxson H. O., Paré P. D., The nature of small-airway obstruction in chronic obstructive pulmonary disease. The New England Journal of Medicine 2004 350 26 2645 2653 2-s2.0-2942720573 10.1056/NEJMoa032158 (Pubitemid 38787999)
49. James A. L., Bai T. R., Mauad T., Abramson M. J., Dolhnikoff M., McKay K. O., Maxwell P. S., Elliot J. G., Green F. H., Airway smooth muscle thickness in asthma is related to severity but not duration of asthma. European Respiratory Journal 2009 34 5 1040 1045 2-s2.0-70349146860 10.1183/09031936.00181608
50. Jeffery P. K., Remodeling in asthma and chronic obstructive lung disease. American Journal of Respiratory and Critical Care Medicine 2001 164 10, part 2 S28 38 2-s2.0-0035891664
51. An S. S., Bai T. R., Bates J. H. T., Black J. L., Brown R. H., Brusasco V., Chitano P., Deng L., Dowell M., Eidelman D. H., Fabry B., Fairbank N. J., Ford L. E., Fredberg J. J., Gerthoffer W. T., Gilbert S. H., Gosens R., Gunst S. J., Halayko A. J., Ingram R. H., Irvin C. G., James A. L., Janssen L. J., King G. G., Knight D. A., Lauzon A. M., Lakser O. J., Ludwig M. S., Lutchen K. R., Maksym G. N., Martin J. G., Mauad T., McParland B. E., Mijallovich S. M., Mitchell H. W., Mitchell R. W., Mitzner W., Murphy T. M., Paré P. D., Pellegrino R., Sanderson M. J., Schellenberg R. R., Seow C. Y., Silveira P. S. P., Smith P. G., Solway J., Stephens N. L., Sterk P. J., Stewart A. G., Tang D. D., Tepper R. S., Tran T., Wang L., Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. European Respiratory Journal 2007 29 5 834 860 2-s2.0-34248204113 10.1183/09031936.00112606 (Pubitemid 46722226)
52. Gosens R., Bos I. S. T., Zaagsma J., Meurs H., Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. American Journal of Respiratory and Critical Care Medicine 2005 171 10 1096 1102 2-s2.0-18644380685 10.1164/rccm.200409-1249OC (Pubitemid 40663720)
53. Grainge C. L., Lau L. C. K., Ward J. A., Dulay V., Lahiff G., Wilson S., Holgate S., Davies D. E., Howarth P. H., Effect of bronchoconstriction on airway remodeling in asthma. The New England Journal of Medicine 2011 364 21 2006 2015 2-s2.0-79957512933 10.1056/NEJMoa1014350
54. Goulet S., Bihl M. P., Gambazzi F., Tamm M., Roth M., Opposite effect of corticosteroids and long-acting β 2- agonits on serum- and TGF- β 1-induced extracellular matrix deposition by primary human lung fibroblasts. Journal of Cellular Physiology 2007 210 1 167 176 2-s2.0-33845463596 10.1002/jcp.20836 (Pubitemid 44904712)
55. Kelly E. A., Jarjour N. N., Role of matrix metalloproteinases in asthma. Current Opinion in Pulmonary Medicine 2003 9 1 28 33 2-s2.0-0037212314 10.1097/00063198-200301000-00005 (Pubitemid 35440967)
56. Rogers D. F., Motor control of airway goblet cells and glands. Respiration Physiology 2001 125 1-2 129 144 2-s2.0-0035126934 10.1016/S0034-5687(00)00209-7 (Pubitemid 32184649)
57. Morcillo E. J., Cortijo J., Mucus and MUC in asthma. Current Opinion in Pulmonary Medicine 2006 12 1 1 6 2-s2.0-33646823963 10.1097/01.mcp.0000198064. 27586.37 (Pubitemid 44378570)
58. Cortijo J., Mata M., Milara J., Donet E., Gavaldà A., Miralpeix M., Morcillo E. J., Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways. European Respiratory Journal 2011 37 2 244 254 2-s2.0-79953646222 10.1183/09031936.00182009
59. Pera T., Zuidhof A., Valadas J., Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. European Respiratory Journal 2011 38 4 789 796
60. Bos I. S. T., Gosens R., Zuidhof A. B., Schaafsma D., Halayko A. J., Meurs H., Zaagsma J., Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. European Respiratory Journal 2007 30 4 653 661 2-s2.0-38449113726 10.1183/09031936.00004907 (Pubitemid 351194824)
61. Arai N., Kondo M., Izumo T., Tamaoki J., Nagai A., Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice. European Respiratory Journal 2010 35 5 1164 1171 2-s2.0-77951962428 10.1183/09031936.00040709
62. Metzen J., Bittinger F., Kirkpatrick C. J., Kilbinger H., Wessler I., Proliferative effect of acetylcholine on rat trachea epithelial cells is mediated by nicotinic receptors and muscarinic receptors of the M1-subtype. Life Sciences 2003 72 18-19 2075 2080 2-s2.0-0037470643 10.1016/S0024-3205(03)00086- 9 (Pubitemid 36298950)
63. Proskocil B. J., Sekhon H. S., Jia Y., Savchenko V., Blakely R. D., Lindstrom J., Spindel E. R., Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 2004 145 5 2498 2506 2-s2.0-2042443069 10.1210/en.2003-1728 (Pubitemid 38535077)
64. Haag S., Matthiesen S., Juergens U. R., Racké K., Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts. European Respiratory Journal 2008 32 3 555 562 2-s2.0-58149376396 10.1183/09031936.00129307
65. Profita M., Bonanno A., Siena L., Bruno A., Ferraro M., Montalbano A. M., Albano G. D., Riccobono L., Casarosa P., Pieper M. P., Gjomarkaj M., Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease. Journal of Pharmacology and Experimental Therapeutics 2009 329 2 753 763 2-s2.0-65649151058 10.1124/jpet.108.145888
66. Kong K. C., Billington C. K., Gandhi U., Panettieri R. A., Penn R. B., Cooperative mitogenic signaling by G protein-coupled receptors and growth factors is dependent on G(q/11). The FASEB Journal 2006 20 9 1558 1560 2-s2.0-33746486393 10.1096/fj.05-5622fje (Pubitemid 44943829)
67. Gosens R., Dueck G., Rector E., Nunes R. O., Gerthoffer W. T., Unruh H., Zaagsma J., Meurs H., Halayko A. J., Cooperative regulation of GSK-3 by muscarinic and PDGF receptors is associated with airway myocyte proliferation. American Journal of Physiology 2007 293 5 L1348 L1358 2-s2.0-36348937450 10.1152/ajplung.00346.2007 (Pubitemid 350159420)
68. Fairbank N. J., Connolly S. C., MacKinnon J. D., Wehry K., Deng L., Maksym G. N., Airway smooth muscle cell tone amplifies contractile function in the presence of chronic cyclic strain. American Journal of Physiology 2008 295 3 L479 L488 2-s2.0-52649100121 10.1152/ajplung.00421.2007
69. Oenema T. A., Smit M., Smedinga L., Racke K., Halayko A. J., Meurs H., Gosens R., Muscarinic receptor stimulation augments TGF- β1-induced contractile protein expression by airway smooth muscle cells. American Journal of Physiology 2012 303 7 L589 L597
70. Ohta S., Oda N., Yokoe T., Tanaka A., Yamamoto Y., Watanabe Y., Minoguchi K., Ohnishi T., Hirose T., Nagase H., Ohta K., Adachi M., Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. Clinical and Experimental Allergy 2010 40 8 1266 1275 2-s2.0-77954357471 10.1111/j.1365-2222.2010.03478.x
71. Cao R., Dong X. W., Jiang J. X., Yan X. F., He J. S., Deng Y. M., Li F. F., Bao M. J., Xie Y. C., Chen X. P., Xie Q. M., M3 muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice. European Journal of Pharmacology 2011 655 1-3 83 90 2-s2.0-79952534622 10.1016/j.ejphar.2011.01.024
72. Papakonstantinou E., Aletras A. J., Roth M., Tamm M., Karakiulakis G., Hypoxia modulates the effects of transforming growth factor- β isoforms on matrix-formation by primary human lung fibroblasts. Cytokine 2003 24 1-2 25 35 2-s2.0-0141987850 10.1016/S1043-4666(03)00253-9 (Pubitemid 37244157)
73. Karakiulakis G., Papakonstantinou E., Aletras A. J., Tamm M., Roth M., Cell type-specific effect of hypoxia and platelet-derived growth factor-BB on extracellular matrix turnover and its consequences for lung remodeling. Journal of Biological Chemistry 2007 282 2 908 915 2-s2.0-33847361673 10.1074/jbc.M602178200 (Pubitemid 47076546)
74. Lagente V., Boichot E., Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. Journal of Molecular and Cellular Cardiology 2010 48 3 440 444 2-s2.0-77649272395 10.1016/j.yjmcc.2009.09.017
75. Papakonstantinou E., Karakiulakis G., The "sweet" and "bitter" involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance. British Journal of Pharmacology 2009 157 7 1111 1127 2-s2.0-70350324902 10.1111/j.1476-5381.2009.00279.x
76. Klagas I., Goulet S., Karakiulakis G., Zhong J., Baraket M., Black J. L., Papakonstantinou E., Roth M., Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD. European Respiratory Journal 2009 34 3 616 628 2-s2.0-70349138334 10.1183/09031936.00070808
77. Cataldo D., Munaut C., Noël A., Frankenne F., Bartsch P., Foidart J. M., Louis R., MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. International Archives of Allergy and Immunology 2000 123 3 259 267 2-s2.0-0033663165
78. Imai K., Dalal S. S., Chen E. S., Downey R., Schulman L. L., Ginsburg M., D'Armiento J., Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. American Journal of Respiratory and Critical Care Medicine 2001 163 3 I 786 791 2-s2.0-0035077465 (Pubitemid 32230844)
79. Asano K., Shikama Y., Shibuya Y., Nakajima H., Kanai K. I., Yamada N., Suzaki H., Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro. International Journal of COPD 2008 3 4 781 790 2-s2.0-60249094602
80. Asano K., Shikama Y., Shoji N., Hirano K., Suzaki H., Nakajima H., Tiotropium bromide inhibits TGF- β -induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro. International Journal of Chronic Obstructive Pulmonary Disease 2010 5 277 286 2-s2.0-79952056758
81. Xie G., Cheng K., Shant J., Raufman J. P., Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells. American Journal of Physiology 2009 296 4 G755 G763 2-s2.0-67149099218 10.1152/ajpgi.90519.2008
82. Papakonstantinou E., Roth M., Karakiulakis G., Isolation and characterization of glycosaminoglycans from human atheromatous vessels. Methods in Molecular Medicine 2001 52 123 136
83. 2-enhanced purinergic and muscarinic signaling in the rat. Neurourology and Urodynamics 2010 29 5 765 770 2-s2.0-77956859160 10.1002/nau.20830
84. Krieg T., Cui L., Qin Q., Cohen M. V., Downey J. M., Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF. Journal of Molecular and Cellular Cardiology 2004 36 3 435 443 2-s2.0-1542298924 10.1016/j.yjmcc.2003.12.013 (Pubitemid 38316948)
85. 2+ store-operated and -independent ionic currents in insulin-secreting HIT-T15 cells and mouse pancreatic β -cells. Journal of Membrane Biology 2004 197 1 59 70 2-s2.0-1242314690 10.1007/s00232-003-0642-y (Pubitemid 38221963)
86. Stelmach I., Jerzyńska J., Bobrowska M., Brzozowska A., Majak P., Kuna P., The effect of inhaled heparin on airway responsiveness to metacholine in asthmatic children. Polskie Archiwum Medycyny Wewnetrznej 2001 106 1 567 572 2-s2.0-0035412215 (Pubitemid 34013712)
87. Ahmed T., Garrigo J., Danta I., Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. The New England Journal of Medicine 1993 329 2 90 95 2-s2.0-0027159470 10.1056/NEJM199307083290204 (Pubitemid 23188822)